Vall d'Hebron
Search

Home > Research Programs > Genitourinary, Central Nervous System (CNS) tumors, Sarcoma and Cancer of Unknown Primary Site Program

More groups

Genitourinary, Central Nervous System (CNS) tumors, Sarcoma and Cancer of Unknown Primary Site Program

Strategic Goals

  1. Implementation of a Urologic Oncology Functional Unit (Vall d’Hebron Urologic Tumors Center).
  2. Consolidation of the Committee on Nervous System Tumors.
  3. Consolidation of the Bone and Soft Tissue Sarcoma Committee.
  4. Development of a translational platform in prostate cancer.

Current objectives

  • Design and development of clinical trials for genitourinary malignancies with the active participation of investigators from the Urology, Radiation Therapy and Medical Oncology Departments.
  • Creation of a translational research platform for Urologic Cancer.
  • Creation of a translational platform for Sarcomas and Basic Research in close collaboration with the Biomedical Research Institute of Bellvitge (IDIBELL) and the Cancer Research Center of Salamanca (CIC).

Team

Joan Carles

Principal Investigator

Medical Oncologists

  • Claudia Valverde MD
  • Jordi Rodón MD

Clinical Fellows

  • Rafael Morales
  • Cristina Suárez

Publications

  • Morales-Barrera R, Valverde C, Rodón J, Pérez J, Maldonado X, Suárez C, Trilla E, Carles J. Bilateral testicular germ cell tumours: a single hospital experience. Clin Transl Oncol 2010 Apr; 12(4): 299-302
  • Carles J, Nogué M, Sole JM, Foro P, Domènech M, Suarez M, Gallardo E, García D, Ferrer F, Gelabert-Mas A, Gayo J, Fabregat X. Phase II study of vinorelbine and estramustine in combination with conformational radiotherapy for patients with high-risk prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2010 Mar; 76(4): 1085-91
  • Carles J, Morales R, Perez JM, Suárez C, Rodón J, Valverde C. Management and interpretation of novel toxicities of molecular targeted therapies: renal toxicities. Eur. J. Cancer 2009 Sep; 45 Suppl 1: 309-17
  • Bellmunt J, Théodore C, Demkov T, Komyakov B, Sengelov L, Daugaard G, Caty A, Carles J, Jagiello-Gruszfeld A, Karyakin O, Delgado FM, Hurteloup P, Winquist E, Morsli N, Salhi Y, Culine S, von der Maase H. Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract. J. Clin. Oncol. 2009 Sep; 27(27): 4454-61
  • Bellmunt J, Macià F, Malmusi D, Llorente JA, Carles J, Lloreta J, Foro P, Gelabert A, Albanell J, Castells X. Impact of PSA implementation and combined radiation and hormonal therapy (RT+HT) on outcome of prostate cancer patients. Eur. J. Cancer 2009 Nov; 45(16): 2804-9

All publications